Page 2 - Andera Life Sciences News Today

Fire1, a remote patient monitoring company for heart failure patients, and Protai, an AI-powered drug discovery platform, scored funding.

EQS-News: Andera Partners / Key word(s): Funds Ahead of its business plan, Andera Partners approaches 4 billion euros in assets under management and announces a new 2028 target of 6 to 8 billion euros 16.02.2023 / 09:00 CET/CEST The issuer is solely responsible for the content of this announceme...

EQS-News: Andera Partners / Key word(s): Financing Andera Partners Participates in the €45 Million Series B Financing of Grey Wolf Therapeutics, led by Pfizer Ventures, to Advance First-of-its-Kind Neoantigen Creation Approaches 26.01.2023 / 13:10 CET/CEST The issuer is solely responsible for th...

EQS-News: Andera Partners / Key word(s): Financing Andera Partners invests in SoniVie, a medtech company developing a promising device for the treatment of hypertension 10.01.2023 / 08:30 CET/CEST The issuer is solely responsible for the content of this announcement. Andera Partners invests in S...

EQS-News: Andera Partners / Key word(s): Financing Andera Partners participates in the $138 Million Series C Financing of Amolyt Pharma led by Sofinnova Partners and co-led by Intermediate

/PRNewswire/ -- SoniVie Ltd. ("SoniVie" or the "Company"), a medical device company developing a proprietary solution to treat hypertension, announced today...

Andera Partners raises its largest life sciences fund at €456M, demonstrating the attractiveness of its activity of the sector

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

DGAP-News: Andera Partners / Key word(s): Personnel Andera Partners strengthens its Life Sciences team with a new partner 07.07.2022 / 10:15 The issuer is solely responsible for

Significant round will enable the Company to advance ICT01, its lead anti-butyrophilin 3A antibody, to completion of randomized Phase II trialsSeries C...